JPMorgan Chase & Co’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-31
| Closed | -$116 | – | 6663 |
|
|
2024
Q3 | $116 | Hold |
31
| – | – | ﹤0.01% | 5909 |
|
|
2024
Q2 | $300 | Sell |
31
-1
| -3% | -$10 | ﹤0.01% | 5712 |
|
|
2024
Q1 | $2.38K | Buy |
32
+16
| +100% | +$1.19K | ﹤0.01% | 5542 |
|
|
2023
Q4 | $2.8K | Buy |
16
+8
| +100% | +$1.4K | ﹤0.01% | 5636 |
|
|
2023
Q3 | $5.61K | Buy |
8
+2
| +33% | +$1.4K | ﹤0.01% | 5418 |
|
|
2023
Q2 | $29.3K | Buy |
6
+1
| +20% | +$4.89K | ﹤0.01% | 4968 |
|
|
2023
Q1 | $14K | Buy |
+5
| New | +$14K | ﹤0.01% | 5215 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6023 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5899 |
|
|
2022
Q2 | – | Sell |
-12
| Closed | -$39K | – | 5979 |
|
|
2022
Q1 | $39K | Sell |
12
-13
| -52% | -$42.3K | ﹤0.01% | 5097 |
|
|
2021
Q4 | $158K | Buy |
25
+15
| +150% | +$94.8K | ﹤0.01% | 4649 |
|
|
2021
Q3 | $91K | Buy |
10
+2
| +25% | +$18.2K | ﹤0.01% | 4763 |
|
|
2021
Q2 | $77K | Buy |
+8
| New | +$77K | ﹤0.01% | 4847 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5418 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5145 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5070 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5003 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4863 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4903 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4940 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4974 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5012 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5008 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4903 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4869 |
|
|
2018
Q1 | – | Hold |
0
| – | -$1K | – | 4808 |
|
|
2017
Q4 | – | Hold |
0
| – | -$1K | – | 4631 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4252 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4377 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4308 |
|